Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Meng-Shih Weng
------>authors3_c=???
------>paper_class1=1
------>Impact_Factor=4.722
------>paper_class3=2
------>paper_class2=1
------>vol=218
------>confirm_bywho=leehorng
------>insert_bywho=hoyuansn
------>Jurnal_Rank=5.3
------>authors4_c=???
------>comm_author=
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=None
------>page2=118
------>medlineContent=
------>unit=E0310
------>insert_date=20071127
------>iam=3
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=???
------>score=500
------>journal_name=Toxicology and Applied Pharmacology
------>paper_name=Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling
------>confirm_date=20071127
------>tch_id=084007
------>pmid=17182072
------>page1=107
------>fullAbstract=Fatty acid synthase (FAS) is a major lipogenic enzyme catalyzing the synthesis of long-chain saturated fatty acids. Most breast cancers require lipogenesis for growth. Here, we demonstrated the effects of theanaphthoquinone (TNQ), a member of the thearubigins generated by the oxidation of theaflavin (TF-1), on the expression of FAS in human breast cancer cells. TNQ was found to suppress the EGF-induced expression of FAS mRNA and FAS protein in MDA-MB-231 cells. Expression of FAS has previously been shown to be regulated by the SREBP family of transcription factors. In this study, we demonstrated that the EGF-induced nuclear translocation of SREBP-1 was blocked by TNQ. Moreover, TNQ also modulated EGF-induced ERK1/2 and Akt phosphorylation. Treatment of MDA-MB-231 cells with PI 3-kinase inhibitors, LY294002 and Wortmannin, inhibited the EGF-induced expression of FAS and nuclear translocation of SREBP-1. Treatment with TNQ inhibited EGF-induced EGFR/ErbB-2 phosphorylation and dimerization. Furthermore, treatment with kinase inhibitors of EGFR and ErbB-2 suggested that EGFR/ErbB-2 activation was involved in EGF-induced FAS expression. In constitutive FAS expression, TNQ inhibited FAS expression and Akt autophosphorylation in BT-474 cells. The PI 3-kinase inhibitors and tyrosine kinase inhibitors of EGFR and ErbB-2 also reduced constitutive FAS expression. In addition, pharmacological blockade of FAS by TNQ decreased cell viability and induced cell death in BT-474 cells. In summary, our findings suggest that TNQ modulates FAS expression by the regulation of EGFR/ErbB-2 pathways and induces cell death in breast cancer cells.
------>tmu_sno=None
------>sno=16272
------>authors2=Chi-Tang Ho
------>authors3=Yuan-Soon Ho
------>authors4=Jen-Kun Lin
------>authors5=
------>authors6=
------>authors6_c=
------>authors=Meng-Shih Weng
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=???
------>publish_area=0
------>updateTitle=Theanaphthoquinone inhibits fatty acid synthase expression in EGF-stimulated human breast cancer cells via the regulation of EGFR/ErbB-2 signaling.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2007
------>submit_flag=None
------>publish_month=1
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z